Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Insulin resistance may result from impaired cytohesin function

Jan. 2, 2007

Otsuka granted Japanese rights to saxagliptin

Dec. 29, 2006

Intranasal PH-80 provides significant improvements in PMS symptoms

Dec. 29, 2006

Encouraging findings for CTCE-0214 in healthy volunteers

Dec. 29, 2006

Positive data for Nastech's PYY(3-36) nasal spray

Dec. 29, 2006

Byetta receives FDA approval

Dec. 28, 2006

Proellex improves bleeding and pain in uterine fibroid patients

Dec. 28, 2006

Altus and Genentech sign agreement for ALTU-238

Dec. 28, 2006

Progress in phase II study of bremelanotide in female sexual dysfunction

Dec. 28, 2006

MBX-2044 begins proof-of-concept phase IIa study for diabetes

Dec. 28, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...